2.50
Hdl Handle:
http://hdl.handle.net/10755/621585
Category:
Full-text
Format:
Text-based Document
Type:
Presentation
Level of Evidence:
N/A
Research Approach:
N/A
Title:
Influenza Virus: The Evolution of a Deadly Virus in Our World
Other Titles:
Global Disease Prevention in Influenza
Author(s):
St. Pierre, Cathy M.
Lead Author STTI Affiliation:
Alpha Chi
Author Details:
Cathy M. St. Pierre, PhD, APRN, FNP, FAANP, Professional Experience: Dr. Cathy St. Pierre is a Family Nurse Practitioner (FNP) with over 30 years of experience in research, practice and academia. She has been nationally certified as an FNP since 1981. She is currently the Associate Chief Nurse of Research and a Nurse Practitioner at the ENRM VA Hospital in Bedford, Massachusetts working in a variety of departments including: pulmonary,Polytrauma/Traumatic Brain Injury care and Homeless veterans program. Dr. St. Pierre is currently involved in research projects focusing on infectious diseases including influenza and hepatitis C viruses. Her background is diversified and she has both taught and practiced clinically in a variety of health care settings and academic institutions. She has presented nationally and internationally on a wide variety of health care/research topics and currently serves on the editorial board of four peer-reviewed professional journals. Author Summary: Dr. Cathy St. Pierre, is a Family Nurse Practitioner and Research Scientist at the ENRM VA Hospital, Bedford, Massachusetts. Her background is diversified and includes expertise in clinical practice, research and academia. Her research expertise includes the role of principal investigator on a multi-year study, focused on influenza viruses. Dr. St. Pierre has expansive professional speaking experiences both nationally and internationally.
Abstract:

Despite significant advances in health care today and the fact that influenza illness is a preventable disease, Influenza virus continues to be a significant cause of morbidity and mortality in the world. Influenza continues to rank in the top 10 causes of death in the world and infects up to 5 million people annually (WHO, 2014). The Influenza virus is compose of three types: A, B and C. Initially, Influenza virus A was thought to be only present in birds and poultry. However, in recent years, it has come to light that strains of the Influenza virus A, known as the Hemagglutinin proteins(HA) and Neuraminidase (NA) protein has infected humans (CDC,2015). Since that time, the HA,NA(known as H#,N#) strains have continued to mutate and it is now known that up that there are 18 subtypes of H proteins and 11 known subtypes of the N proteins (CDC, 2015). Because of the mutation of these influenza virus proteins over the past several years (2003-2015), mortality rates from influenza, in several countries has risen to greater than 50% (WHO, 2015). In 2012, the Global Influenza Initiative (GII) was created to establish the scientific evidence for the worldwide burden of disease attributable to Influenza virus (Paget, 2015).

 

 Generally, the “flu” infects up to 20% of the general population and will result in over 500,000 deaths each year. Unfortunately, some of our most vulnerable populations: infants, pregnant females and the elderly, are at greatest risk for contracting this disease (Cheng et al, 2015). For example, In 2010, 90% of the influenza deaths that occurred in the USA, were in the elderly population (Heron, 2013). This is despite the fact that the elderly population as a whole, represent the highest compliance rates for immunization (65%).

 

This presentation will focus on the evolution of influenza viruses throughout the world and the current strategies in place to monitor disease incidence, prevalence and current recommendations for prevention and treatment of both the general and at risk populations. The new quadrivalent and high-dose vaccines will also be discussed as well as policies related to the risk, benefits and effectiveness of these vaccines. (Demicheli et al, 2014).

Keywords:
Disease Prevention; Influenza Viruses; Vulnerable Populations
Repository Posting Date:
22-Jun-2017
Date of Publication:
22-Jun-2017
Other Identifiers:
INRC17P03
Conference Date:
2017
Conference Name:
28th International Nursing Research Congress
Conference Host:
Sigma Theta Tau International
Conference Location:
Dublin, Ireland
Description:
Event Theme: Influencing Global Health Through the Advancement of Nursing Scholarship

Full metadata record

DC FieldValue Language
dc.language.isoen_USen
dc.type.categoryFull-texten
dc.formatText-based Documenten
dc.typePresentationen
dc.evidence.levelN/Aen
dc.research.approachN/Aen
dc.titleInfluenza Virus: The Evolution of a Deadly Virus in Our Worlden_US
dc.title.alternativeGlobal Disease Prevention in Influenzaen
dc.contributor.authorSt. Pierre, Cathy M.en
dc.contributor.departmentAlpha Chien
dc.author.detailsCathy M. St. Pierre, PhD, APRN, FNP, FAANP, Professional Experience: Dr. Cathy St. Pierre is a Family Nurse Practitioner (FNP) with over 30 years of experience in research, practice and academia. She has been nationally certified as an FNP since 1981. She is currently the Associate Chief Nurse of Research and a Nurse Practitioner at the ENRM VA Hospital in Bedford, Massachusetts working in a variety of departments including: pulmonary,Polytrauma/Traumatic Brain Injury care and Homeless veterans program. Dr. St. Pierre is currently involved in research projects focusing on infectious diseases including influenza and hepatitis C viruses. Her background is diversified and she has both taught and practiced clinically in a variety of health care settings and academic institutions. She has presented nationally and internationally on a wide variety of health care/research topics and currently serves on the editorial board of four peer-reviewed professional journals. Author Summary: Dr. Cathy St. Pierre, is a Family Nurse Practitioner and Research Scientist at the ENRM VA Hospital, Bedford, Massachusetts. Her background is diversified and includes expertise in clinical practice, research and academia. Her research expertise includes the role of principal investigator on a multi-year study, focused on influenza viruses. Dr. St. Pierre has expansive professional speaking experiences both nationally and internationally.en
dc.identifier.urihttp://hdl.handle.net/10755/621585-
dc.description.abstract<p>Despite significant advances in health care today and the fact that influenza illness is a preventable disease, Influenza virus continues to be a significant cause of morbidity and mortality in the world. Influenza continues to rank in the top 10 causes of death in the world and infects up to 5 million people annually (WHO, 2014). The Influenza virus is compose of three types: A, B and C. Initially, Influenza virus A was thought to be only present in birds and poultry. However, in recent years, it has come to light that strains of the Influenza virus A, known as the Hemagglutinin proteins(HA) and Neuraminidase (NA) protein has infected humans (CDC,2015). Since that time, the HA,NA(known as H#,N#) strains have continued to mutate and it is now known that up that there are 18 subtypes of H proteins and 11 known subtypes of the N proteins (CDC, 2015). Because of the mutation of these influenza virus proteins over the past several years (2003-2015), mortality rates from influenza, in several countries has risen to greater than 50% (WHO, 2015). In 2012, the Global Influenza Initiative (GII) was created to establish the scientific evidence for the worldwide burden of disease attributable to Influenza virus (Paget, 2015).</p> <p> </p> <p> Generally, the “flu” infects up to 20% of the general population and will result in over 500,000 deaths each year. Unfortunately, some of our most vulnerable populations: infants, pregnant females and the elderly, are at greatest risk for contracting this disease (Cheng et al, 2015). For example, In 2010, 90% of the influenza deaths that occurred in the USA, were in the elderly population (Heron, 2013). This is despite the fact that the elderly population as a whole, represent the highest compliance rates for immunization (65%).</p> <p> </p> <p>This presentation will focus on the evolution of influenza viruses throughout the world and the current strategies in place to monitor disease incidence, prevalence and current recommendations for prevention and treatment of both the general and at risk populations. The new quadrivalent and high-dose vaccines will also be discussed as well as policies related to the risk, benefits and effectiveness of these vaccines. (Demicheli et al, 2014).</p>en
dc.subjectDisease Preventionen
dc.subjectInfluenza Virusesen
dc.subjectVulnerable Populationsen
dc.date.available2017-06-22T20:32:49Z-
dc.date.issued2017-06-22-
dc.date.accessioned2017-06-22T20:32:49Z-
dc.conference.date2017en
dc.conference.name28th International Nursing Research Congressen
dc.conference.hostSigma Theta Tau Internationalen
dc.conference.locationDublin, Irelanden
dc.descriptionEvent Theme: Influencing Global Health Through the Advancement of Nursing Scholarshipen
All Items in this repository are protected by copyright, with all rights reserved, unless otherwise indicated.